Preferred Label : givosiran;
UNII : ROV204583W;
Origin ID : C000630124;
UMLS CUI : C4688584;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3258964/fr/givlaari
2021
false
false
false
France
Givosiran
givosiran
acetylgalactosamine
pyrrolidines
insurance, health, reimbursement
adult
porphyria, acute hepatic
injections, subcutaneous
evaluation of the transparency committee
porphyrias, hepatic
porphobilinogen synthase
porphobilinogen synthase
givosiran
---
https://www.ema.europa.eu/en/medicines/human/EPAR/givlaari
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
acute disease
porphyrias, hepatic
drug approval
europe
product surveillance, postmarketing
adult
adolescent
injections, subcutaneous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
porphyria, acute hepatic
givosiran
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran
---
https://www.has-sante.fr/jcms/p_3191915/fr/givlaari
2020
false
false
false
France
Givosiran
Givosiran
acetylgalactosamine
pyrrolidines
givosiran
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
porphyrias, hepatic
acute disease
porphyria, acute hepatic
guidelines for drug use
continuity of patient care
evaluation of the transparency committee
porphobilinogen synthase
porphobilinogen synthase
givosiran
givosiran
---
